Nasdaq Oprx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OptimizeRx (NASDAQ:OPRX – Get Free Report) and ICTS International (OTCMKTS:ICTSF – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. Earnings and Valuation This table compares […]

JMP Securities reissued their market outperform rating on shares of OptimizeRx (NASDAQ:OPRX – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $15.00 price target on the stock. A number of other brokerages also recently commented on OPRX. Royal Bank of Canada reissued an outperform rating and […]

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that […]

JMP Securities reissued their market outperform rating on shares of OptimizeRx (NASDAQ:OPRX – Free Report) in a research report released on Tuesday, Benzinga reports. JMP Securities currently has a $15.00 target price on the stock. Several other brokerages have also commented on OPRX. Stifel Nicolaus restated a buy rating and set a $13.00 target price […]

Citigroup Inc. decreased its position in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 45.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,189 shares of the company’s stock after selling 5,070 shares during the period. Citigroup Inc.’s […]